Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer

BJU International

Volumn 98, Issue 6, 2006, Pages 1193-1198

  Ficarra, Vincenzo ^a   Antoniolli, Stefano Zecchini ^a   Novara, Giacomo ^b   Parisi, Alice ^a   Fracalanza, Simonetta ^b   Martignoni, Guido ^a   Artibani, Walter ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Complications; HIFU; High intensity focused ultrasound; Prostatic neoplasm; Urinary continence

Indexed keywords

CIPROFLOXACIN; GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLADDER OBSTRUCTION; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; DRAIN; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; IMMUNOASSAY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STENOSIS; URINARY TRACT INFECTION;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 33750853808     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06561.x     Document Type: Article

References (25)

1. Lynn LG, Putnam TJ. Histological and cerebral lesions produced by focused ultrasound. Am J Pathol 1944; 20: 637-49
2. Chaussy C, Thuroff S, Rebillard X, Gelet A. Technology insight: high-intensity focused ultrasound for urologic cancers. Nat Clin Prac Urol 2005; 2: 191-8
3. Chapelon JY, Margonari J, Theillere Y et al. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 1992; 22: 147-52
4. Chapelon JY, Margonari J, Vernier F, Gorry F, Ecochard R, Gelet A. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 1992; 52: 6353-7
5. Gelet A, Chapelon JY, Margonari J et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993; 7: 249-53
6. Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248-52
7. Poissonnier L, Gelet A, Chapelon JY et al. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml)]. Prog Urol 2003; 13: 60-72
8. Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004; 63: 297-300
9. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 2004; 171: 2265-7
10. Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004; 63: 625-9
11. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74
12. Ficarra V, Novella G, Novara G et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol 2005; 48: 932-7
13. The National Comprehensive Cancer Network. Clinical Practice Guidelines on Prostate Cancer Version 2 2005 Available at: http://www.nccn.org/ professionals/physician_gls/pdf/prostate.pdf. Accessed July 2006
14. Lawton CA, Winter K, Murray K. Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001; 49: 937-46
15. Pilepich MV, Winter K, John MJ et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001; 50: 1243-52
16. Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103-6
17. Hanks GE, Pajak TF, Porter A et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 2003; 21: 3972-8
18. McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP; Casodex Early Prostate Cancer Trialists' Group. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int 2006; 97: 247-54
19. Novella G, Ficarra V, Galfano A et al. Pain assessment after original transperineal prostate biopsy using a coaxial needle. Urology 2003; 62: 689-92
20. Algaba F, Epstein JI, Aldape HC et al. Assessment of prostate carcinoma in core needle biopsy - definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996; 78: 376-81
21. Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2005; 48: 546-51
22. Stock RG, Stone NN, DeWyngaert JK, Lavagnini P, Unger PD. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 1996; 77: 2386-92
23. Prestidge BR, Hoak DC, Grimm PD, Ragde H, Cavanagh W, Blasko JC. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 31-9
24. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999; 161: 156-62
25. Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001; 15: 437-40